相关实验视频
Updated: Jul 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
闭环胰岛素输送系统适用于1型糖尿病患者和慢性代谢控制非常差的人:它有效且安全!
Sonia Deepchand1, Vanessa Balla1, Juliette Eroukhmanoff1
1Diabetes Department, Sud-Francilien Hospital, Corbeil-Essonnes, France.
有较差血糖控制的1型糖尿病患者中有一半接受了混合闭环 (HCL) 胰岛素系统. 那些使用HCL的人显示出显著的HbA1c降低,并保持安全,这表明HCL是一个可行的选择.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 生物医学工程 生物医学工程
背景情况:
- 1型糖尿病 (T1D) 的管理仍然具有挑战性,特别是对于代谢控制非常差的人 (HbA1c>11%) 来说.
- 混合闭环 (HCL) 胰岛素输送系统为改善血糖结果提供了潜在的技术解决方案.
研究的目的:
- 确定HCL系统在T1D患者中接受率,其中代谢控制非常差.
- 评估HCL在一年内在这个人群中使用的代谢改善和安全概况.
主要方法:
- 一项单中心研究确定了T1D患者 (年龄大于18岁) 的基线HbA1c>11%.
- 患者被提供HCL治疗,并记录了接受.
- 代谢控制 (HbA1c) 和安全数据在HCL启动后长达一年收集.
主要成果:
- 在65名符合条件的患者中,32名 (50%) 接受或继续使用HCL.
- 在使用HCL的人群中,一年后平均HbA1c显著下降,从12.5%降至9.4% (P < 0.001).
- 急性代谢事件的发生率与HCL前期相比仍然相当.
结论:
- HCL胰岛素输送系统是T1D患者具有非常差的代谢控制的可行和有效的治疗选择.
- 在这个具有挑战性的患者群体中,采用HCL可以导致血糖水平的大幅改善,并保持安全.
更多相关视频
09:31Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres
Published on: November 5, 2016
11:57Scaffold-supported Transplantation of Islets in the Epididymal Fat Pad of Diabetic Mice
Published on: July 23, 2017
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...